Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Related Posts
Cipla in talks for a private-equity deal? Here’s what could be on the mind of founder Yusuf Hamied.
Friends, I represent the Third World. I represent the needs and aspirations of the Third World. I represent the capabilities…
Kotdwar to Hyderabad: How a fake-drugs racket in Uttarakhand with roots in south India was busted.
Officials from enforcement agencies with the accused charged with making and supplying spurious drugs; image credit: Telangana Drug Control Administration…
What’s making GBS nerve disorder go viral in Pune
Getty Images Guillain-Barre syndrome (GBS) test, a rare disorder where the body’s immune system damages nerve Synopsis Guillain-Barré Syndrome is…
